IRIS
GOZZO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.034
AS - Asia 633
EU - Europa 507
SA - Sud America 140
AF - Africa 112
OC - Oceania 5
Totale 2.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.019
SG - Singapore 351
IT - Italia 237
CN - Cina 188
IE - Irlanda 163
BR - Brasile 130
CI - Costa d'Avorio 55
KR - Corea 47
SN - Senegal 39
NL - Olanda 23
IN - India 19
FI - Finlandia 17
DE - Germania 12
UA - Ucraina 12
BE - Belgio 10
CA - Canada 9
VN - Vietnam 9
NG - Nigeria 8
RU - Federazione Russa 7
SE - Svezia 6
AU - Australia 5
GB - Regno Unito 5
ZA - Sudafrica 5
BD - Bangladesh 4
TR - Turchia 4
AR - Argentina 3
AT - Austria 3
MX - Messico 3
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
KE - Kenya 2
NO - Norvegia 2
OM - Oman 2
PL - Polonia 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BS - Bahamas 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
FR - Francia 1
GR - Grecia 1
HN - Honduras 1
JP - Giappone 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.431
Salva come PNG Salva come JPEG
Città #
Santa Clara 376
Singapore 226
Dublin 162
Hefei 100
Chicago 82
Boardman 80
Ashburn 78
Chandler 64
Abidjan 55
Seoul 47
Civitanova Marche 39
Dakar 39
Catania 30
Rome 25
Los Angeles 21
Washington 19
Amsterdam 18
Pune 11
Brussels 10
Campobasso 9
Milan 9
Abuja 8
Palermo 8
São Paulo 8
Cambridge 7
Helsinki 7
Lawrence 7
New York 7
Seattle 7
Andover 6
Rio de Janeiro 6
Stockholm 6
Beijing 5
Council Bluffs 5
Des Moines 5
Jacksonville 5
Munich 5
Assago 4
Assoro 4
Bologna 4
Dong Ket 4
Gela 4
Melbourne 4
Reggio Calabria 4
Turku 4
Anápolis 3
Augusta 3
Belo Horizonte 3
Brooklyn 3
Castelraimondo 3
Columbus 3
Espoo 3
Florence 3
Lamezia Terme 3
Lappeenranta 3
Messina 3
Piazzola Sul Brenta 3
San Francisco 3
San Giovanni la Punta 3
Shenyang 3
The Dalles 3
Adamantina 2
Atlanta 2
Bari 2
Betim 2
Brasília 2
Cabo Frio 2
Caruaru 2
Cernusco sul Naviglio 2
Charlotte 2
Coimbatore 2
Curitiba 2
Dallas 2
Formia 2
Franca 2
Guangzhou 2
Guarulhos 2
Haiphong 2
Hanoi 2
Hebei 2
Hengyang 2
Hong Kong 2
Itaquaquecetuba 2
Johannesburg 2
London 2
Montreal 2
Nairobi 2
Nanaimo 2
Nanjing 2
Naples 2
Olomouc 2
Pretoria 2
Secaucus 2
Warsaw 2
Afogados da Ingazeira 1
Aktau 1
Alexandria 1
Alterosa 1
Alvorada 1
Ananindeua 1
Totale 1.754
Salva come PNG Salva come JPEG
Nome #
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 92
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 80
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 72
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 72
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 71
Fluoxetine Protects Retinal Ischemic Damage in Mice 68
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 66
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure 65
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 65
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 60
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies 60
Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue 58
Sviluppo ed uso dei farmaci: dal laboratorio alla clinica. 56
Linking the Price of Cancer Drug Treatments to Their Clinical Value 54
Accesso ai medicinali innovativi per indicazioni neurologiche in Europa: allineamento delle valutazioni di Health Technology Assessment tra i Paesi Europei 54
EMA: l’ente che vigila sui medicinali che circolano nella Comunità Europea 52
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 50
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries 49
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation 48
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) 47
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? 47
Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries 46
Response to Letter to the Editor by Dr. Garattini 46
Beyond the budget silo approach: estimating health system sustainability for future dementia drugs 45
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 44
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap 43
Editorial: Innovation in ocular pharmacology 42
Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution 41
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 39
COVID-19 Disease and Vitamin D: A Mini-Review 39
Anemia Mediterranea o talassemia: c’è qualcosa per evitare le trasfusioni? 39
Periodontal Disease and Pregnancy: Correlation with Underweight Birth 37
AIFA: l’ente che autorizza un nuovo farmaco, una nuova formulazione o una nuova indicazione in Italia 37
OFF-LABEL USE OF MEDICINES: A CLINICAL AND REGULATORY OPPORTUNITYTHE. 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 37
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved? 36
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) 36
Attitude survey of spontaneous adverse drug-reaction reporting by general practitioners in Sicily 36
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience 36
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence 35
Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation 35
Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA 33
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review 33
Starting Dose Of Non-Vitamin K Antagonist Oral Anticoagulation Agents In Patients With Atrial Fibrillation: Data From Italian Monitoring Registries 33
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2019. Roma: Agenzia Italiana del Farmaco, 2020. 31
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study) 31
Editorial: Innovative treatments for neuro-psychiatric diseases 30
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2018. Roma: Agenzia Italiana del Farmaco, 2019 29
Obesità e farmaci: quando servono e quali usare 28
SARS-Cov-2 Damage on the Nervous System and Mental Health 28
La sclerosi multipla: una malattia invalidante con nuove possibilità di cura 27
Più che una speranza, oggi è una certezza la possibilità di ridurre la gravità dell’atrofia muscolare spinale 27
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries 26
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of Action 26
Quali farmaci usare per l’età pediatrica? 26
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota 25
Prevenzione e terapia dell’osteoporosi: quali farmaci sono utili e cosa c’è di nuovo 25
Scheda informativa Tocilizumab per uso endovenoso nel trattamento di pazienti gravi con COVID-19 25
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 22
Asma: vecchi e nuovi farmaci e attenzione al CoViD-19 10
Totale 2.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 1 0 3 0 1 0 1 3 3 5
2021/202275 1 6 3 1 8 5 6 1 10 10 5 19
2022/2023500 8 11 4 10 80 99 31 102 118 1 24 12
2023/2024448 18 58 35 42 26 97 21 39 3 13 62 34
2024/20251.404 19 161 62 64 312 162 71 40 91 110 135 177
2025/202688 88 0 0 0 0 0 0 0 0 0 0 0
Totale 2.550